欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NO/H/0287/001
药品名称Bortezomib
活性成分
    • BORTEZOMIB 3.5 mg
剂型Powder for solution for injection
上市许可持有人Synchrony Pharma Ltd Business & Technology Centre, Bessemer Drive SG1 2DX Stevenage, United Kingdom
参考成员国 - 产品名称Norway (NO)
Bortezomib Synchrony
互认成员国 - 产品名称
    许可日期2018/07/27
    最近更新日期2021/08/26
    药物ATC编码
      • L01XX32 bortezomib
    申请类型
    • TypeLevel1:Known Active Substance
    • TypeLevel2:Initial Application
    • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
      市场状态Withdrawn(注:已撤市)
      ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase